Application Note

In Situ Leak Testing, Integrity Testing, And PUPSIT For Flow Kits Using The Manual Drug Product Filtration System

Source: Cytiva
GettyImages-2158441715-titration-analysis-scientist-flask-analysis

Final drug product filtration is a critical safeguard in sterile drug manufacturing, ensuring patient safety by removing contaminants before filling vials or syringes. To strengthen contamination control, updated EU GMP Annex 1 guidelines recommend pre-use post-sterilization integrity testing (PUPSIT) for sterilizing-grade filters. Implementing PUPSIT helps verify filter integrity after sterilization, reducing risks from damage during handling or installation. A manual filtration system configured for single or redundant filter arrangements enables in situ leak testing, filter wetting, and both pre- and post-use integrity checks. These steps confirm a closed, sterile flow path and minimize contamination risk throughout the process. Performance data from typical applications demonstrate reliability across multiple filter sizes and membrane types commonly used for sterile drug filtration.

Explore how robust filtration practices and integrity testing can enhance compliance and product safety.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene